Joachim Y. Doua

Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.

A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.

Journal: Epidemiology and infection

Published: September 03, 2025

A qualitative burden of disease study in patients with invasive Escherichia coli disease aged ≥ 60 years in the United States.

A qualitative burden of disease study in patients with invasive Escherichia coli disease aged ≥ 60 years in the United States.

Journal: BMC infectious diseases

Published: April 17, 2025

Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challenges.

Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challenges.

Journal: Vaccine

Published: May 21, 2024

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial.

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial.

Journal: Human vaccines & immunotherapeutics

Published: March 25, 2024

A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.

A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.

Journal: The Journal of antimicrobial chemotherapy

Published: February 05, 2024

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.

Journal: Infection

Published: August 16, 2023

Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.

Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: April 19, 2023

Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.

Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.

Journal: Open forum infectious diseases

Published: April 05, 2023

Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals.

Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals.

Journal: Open forum infectious diseases

Published: March 14, 2022

Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.

Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.

Journal: Pharmacoepidemiology and drug safety

Published: January 31, 2022

Performance characteristics of code-based algorithms to identify urinary tract infections in large United States administrative claims databases.

Performance characteristics of code-based algorithms to identify urinary tract infections in large United States administrative claims databases.

Journal: Pharmacoepidemiology and drug safety

Published: November 09, 2021

Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.

Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.

Journal: International journal of antimicrobial agents

Published: May 21, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026